RxTeach
  • Home
  • Clinical Pharmacy
  • Journal Clubs
  • Pharmacy Industry
  • Health & Wellness
  • Students
  • Donations
  • About
  • Day in the Life
  • Science
  • Connect with us!
Sign in Subscribe
Clinical Pharmacy

Let's Talk Vancomycin: Part 2

Today, we’ll continue our deep dive with vanc and learn more about how we might approach dosing and calculations!

  • Justin Shiau, PharmD

Justin Shiau, PharmD

20 Feb 2025 • 16 min read
Share
Let's Talk Vancomycin: Part 2
Photo by insung yoon / Unsplash

This post is for subscribers only

Subscribe now

Already have an account? Sign in

Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE)

Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE)

The need to evaluate both costs and benefits of healthcare interventions has made Health Economics and Outcomes Research increasingly important in healthcare today.
16 Jul 2026 4 min read
Understanding Botox Treatment for Cerebral Palsy

Understanding Botox Treatment for Cerebral Palsy

“Cerebral”: having to do with the brain. “Palsy”: weakness in or muscle functioning issues.
15 Jul 2026 6 min read
DOACs for Venous Thromboembolism: Which is the Best?

DOACs for Venous Thromboembolism: Which is the Best?

A practical comparison of DOACs for VTE, covering indications, dosing, bleeding risk, renal considerations, and reversal.
09 Jul 2026 8 min read
RxTeach © 2026
Powered by Ghost